ZARA BOGENSCHUTZ: Open Payments
NPI 1639691199 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,330 in 111 payments from 25 companies in 2025. Trend: 2023 $2,594 · 2024 $2,957 · 2025 $3,330
Food & beverage: $3,330
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 14 | $1,201 |
| ABBVIE INC. | 27 | $553 |
| Novartis Pharmaceuticals Corporation | 19 | $372 |
| Biogen, Inc. | 7 | $205 |
| TG Therapeutics, Inc. | 6 | $128 |
| UCB, Inc. | 3 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Alexion Pharmaceuticals, Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $70 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
Products named: KESIMPTA, QULIPTA, BOTOX, BRIUMVI, AVONEX, VYALEV, Mavenclad, PONVORY.
Industry payments across IN — which companies pay providers there.
